Cargando…
NDRG1 promotes endothelial dysfunction and hypoxia-induced pulmonary hypertension by targeting TAF15
BACKGROUND: Pulmonary hypertension (PH) represents a threatening pathophysiologic state that can be induced by chronic hypoxia and is characterized by extensive vascular remodeling. However, the mechanism underlying hypoxia-induced vascular remodeling is not fully elucidated. METHODS AND RESULTS: By...
Autores principales: | Li, Chengwei, Lv, Junzhu, Wumaier, Gulinuer, Zhao, Yu, Dong, Liang, Zeng, Yuzhen, Zhu, Ning, Zhang, Xiujuan, Wang, Jing, Xia, Jingwen, Li, Shengqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599394/ https://www.ncbi.nlm.nih.gov/pubmed/37885911 http://dx.doi.org/10.1093/pcmedi/pbad024 |
Ejemplares similares
-
Mxi1-0 Promotes Hypoxic Pulmonary Hypertension Via ERK/c-Myc-dependent Proliferation of Arterial Smooth Muscle Cells
por: Dong, Liang, et al.
Publicado: (2022) -
Cefminox, a Dual Agonist of Prostacyclin Receptor and Peroxisome Proliferator-Activated Receptor-Gamma Identified by Virtual Screening, Has Therapeutic Efficacy against Hypoxia-Induced Pulmonary Hypertension in Rats
por: Xia, Jingwen, et al.
Publicado: (2018) -
EphrinA3 is a key regulator of malignant behaviors and a potential prognostic factor in lung adenocarcinoma
por: Yiminniyaze, Ruzetuoheti, et al.
Publicado: (2022) -
Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling
por: Wang, Jing, et al.
Publicado: (2022) -
Chemotherapy in combination with pembrolizumab and antiangiogenesis
in young patients with advanced primary pulmonary mucinous adenocarcinoma: Two
case reports
por: Zhou, Daibing, et al.
Publicado: (2021)